Oncternal Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is December - November.

Millions GBP. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 13, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Market Capitalization	1	1	4	12	16	-
Market Cap Growth	-74.97%	-74.97%	-71.15%	-25.71%	-	-
Enterprise Value	1	1	3	11	16	-
Last Close Price	0.00	0.01	0.04	0.13	0.17	-
PS Ratio	8.13	12.89	12.60	69.37	2723.70	-
PB Ratio	0.37	0.59	1.70	3.74	3.10	-
P/TBV Ratio	-	-	-	13.50	5.57	-
EV/Sales Ratio	7.85	13.84	12.17	60.68	2731.87	-
Debt / Equity Ratio	0.01	0.01	0.06	0.05	0.04	-4.03
Asset Turnover	0.03	0.03	0.09	0.04	0.00	-
Inventory Turnover	1.33	1.33	2.10	-	-	-
Quick Ratio	0.15	0.15	0.38	5.54	23.03	0.88
Current Ratio	0.27	0.27	0.61	5.80	23.03	0.88
Return on Equity (ROE)	-69.63%	-69.63%	-63.62%	-47.68%	-44.32%	-
Return on Assets (ROA)	-32.77%	-32.77%	-39.66%	-27.44%	-24.46%	-
Return on Capital (ROIC)	-48.76%	-48.76%	-45.78%	-28.46%	-25.18%	-
Earnings Yield	-224.06%	-141.26%	-48.17%	-16.74%	-7.07%	-
FCF Yield	-	-84.44%	-33.81%	-17.73%	-6.44%	-
Buyback Yield / Dilution	-29.13%	-29.13%	-135.44%	-	-	-

Updated Aug 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.